These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 26359290)

  • 1. Multiple sclerosis associated genetic variants of CD226 impair regulatory T cell function.
    Piédavent-Salomon M; Willing A; Engler JB; Steinbach K; Bauer S; Eggert B; Ufer F; Kursawe N; Wehrmann S; Jäger J; Reinhardt S; Friese MA
    Brain; 2015 Nov; 138(Pt 11):3263-74. PubMed ID: 26359290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD226 ligation protects against EAE by promoting IL-10 expression via regulation of CD4+ T cell differentiation.
    Zhang R; Zeng H; Zhang Y; Chen K; Zhang C; Song C; Fang L; Xu Z; Yang K; Jin B; Wang Q; Chen L
    Oncotarget; 2016 Apr; 7(15):19251-64. PubMed ID: 26942885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Divergent Phenotypes of Human Regulatory T Cells Expressing the Receptors TIGIT and CD226.
    Fuhrman CA; Yeh WI; Seay HR; Saikumar Lakshmi P; Chopra G; Zhang L; Perry DJ; McClymont SA; Yadav M; Lopez MC; Baker HV; Zhang Y; Li Y; Whitley M; von Schack D; Atkinson MA; Bluestone JA; Brusko TM
    J Immunol; 2015 Jul; 195(1):145-55. PubMed ID: 25994968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the Multiple Sclerosis-Associated Genetic Variant
    Morandi E; Adoue V; Bernard I; Friebel E; Nunez N; Aubert Y; Masson F; Dejean AS; Becher B; Astier A; Martinet L; Saoudi A
    Neurol Neuroimmunol Neuroinflamm; 2024 Nov; 11(6):e200306. PubMed ID: 39231385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CD6 multiple sclerosis susceptibility allele is associated with alterations in CD4+ T cell proliferation.
    Kofler DM; Severson CA; Mousissian N; De Jager PL; Hafler DA
    J Immunol; 2011 Sep; 187(6):3286-91. PubMed ID: 21849685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T-cell function and FOXP3 expression.
    Venken K; Hellings N; Hensen K; Rummens JL; Medaer R; D'hooghe MB; Dubois B; Raus J; Stinissen P
    J Neurosci Res; 2006 Jun; 83(8):1432-46. PubMed ID: 16583400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-E restricted CD8+ T cell subsets are phenotypically altered in multiple sclerosis patients.
    Pannemans K; Broux B; Goris A; Dubois B; Broekmans T; Van Wijmeersch B; Geraghty D; Stinissen P; Hellings N
    Mult Scler; 2014 Jun; 20(7):790-801. PubMed ID: 24144875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD226 deficiency on regulatory T cells aggravates renal fibrosis via up-regulation of Th2 cytokines through miR-340.
    Mu Y; Zhang J; Liu Y; Ma J; Jiang D; Zhang X; Yi X; Cheng K; Shen S; Yang Y; Zhuang R; Zhang Y
    J Leukoc Biol; 2020 Apr; 107(4):573-587. PubMed ID: 31802539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New candidates for CD4 T cell pathogenicity in experimental neuroinflammation and multiple sclerosis.
    Hoppmann N; Graetz C; Paterka M; Poisa-Beiro L; Larochelle C; Hasan M; Lill CM; Zipp F; Siffrin V
    Brain; 2015 Apr; 138(Pt 4):902-17. PubMed ID: 25665584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Astrocytic Fas ligand expression is required to induce T-cell apoptosis and recovery from experimental autoimmune encephalomyelitis.
    Wang X; Haroon F; Karray S; Martina Deckert ; Schlüter D
    Eur J Immunol; 2013 Jan; 43(1):115-24. PubMed ID: 23011975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD226 attenuates Treg suppressive capacity via CTLA-4 and TIGIT during EAE.
    Wang N; Liang S; Jin J; Fang L; Ma Q; Wang X; Song Y; Chen L
    Immunol Res; 2019 Dec; 67(6):486-496. PubMed ID: 31919790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNFR2 on non-haematopoietic cells is required for Foxp3+ Treg-cell function and disease suppression in EAE.
    Tsakiri N; Papadopoulos D; Denis MC; Mitsikostas DD; Kollias G
    Eur J Immunol; 2012 Feb; 42(2):403-12. PubMed ID: 22105853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 3'-untranslated region variant is associated with impaired expression of CD226 in T and natural killer T cells and is associated with susceptibility to systemic lupus erythematosus.
    Löfgren SE; Delgado-Vega AM; Gallant CJ; Sánchez E; Frostegård J; Truedsson L; de Ramón Garrido E; Sabio JM; González-Escribano MF; Pons-Estel BA; D'Alfonso S; Witte T; Lauwerys BR; Endreffy E; Kovács L; Vasconcelos C; Martins da Silva B; Martín J; Alarcón-Riquelme ME; Kozyrev SV
    Arthritis Rheum; 2010 Nov; 62(11):3404-14. PubMed ID: 20669283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An acidic polysaccharide of Panax ginseng ameliorates experimental autoimmune encephalomyelitis and induces regulatory T cells.
    Hwang I; Ahn G; Park E; Ha D; Song JY; Jee Y
    Immunol Lett; 2011 Aug; 138(2):169-78. PubMed ID: 21524666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD44 variant isoforms control experimental autoimmune encephalomyelitis by affecting the lifespan of the pathogenic T cells.
    Ghazi-Visser L; Laman JD; Nagel S; van Meurs M; van Riel D; Tzankov A; Frank S; Adams H; Wolk K; Terracciano L; Melief MJ; Sabat R; Günthert U
    FASEB J; 2013 Sep; 27(9):3683-701. PubMed ID: 23752202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovery of CD226-TIGIT
    Long Y; Wang C; Xia C; Li X; Fan C; Zhao X; Liu C
    Immunol Lett; 2020 Feb; 218():30-39. PubMed ID: 31883787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased numbers and suppressive activity of regulatory CD25(+)CD4(+) T lymphocytes in the absence of CD4 engagement by MHC class II molecules.
    Shen X; Niu C; König R
    Cell Immunol; 2013 Apr; 282(2):117-28. PubMed ID: 23770721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased CD226 Expression on CD8+ T Cells Is Associated with Upregulated Cytokine Production and Endothelial Cell Injury in Patients with Systemic Sclerosis.
    Ayano M; Tsukamoto H; Kohno K; Ueda N; Tanaka A; Mitoma H; Akahoshi M; Arinobu Y; Niiro H; Horiuchi T; Akashi K
    J Immunol; 2015 Aug; 195(3):892-900. PubMed ID: 26109642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
    Fletcher JM; Lonergan R; Costelloe L; Kinsella K; Moran B; O'Farrelly C; Tubridy N; Mills KH
    J Immunol; 2009 Dec; 183(11):7602-10. PubMed ID: 19917691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single nucleotide polymorphisms in the FOXP3 gene are associated with increased risk of relapsing-remitting multiple sclerosis.
    Eftekharian MM; Sayad A; Omrani MD; Ghannad MS; Noroozi R; Mazdeh M; Mirfakhraie R; Movafagh A; Roshanaei G; Azimi T; Inoko H; Taheri M
    Hum Antibodies; 2016; 24(3-4):85-90. PubMed ID: 27792007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.